Istaroxime: A rising star in acute heart failure

Journal of Pharmacology and Pharmacotherapeutics

Volumn 3, Issue 4, 2012, Pages 353-355

  Aditya, Suruchi ^a   Rattan, Aditya ^b  

^a PANJAB UNIVERSITY   (India)

^b Heartline Panchkula ^*  (India)

Author keywords

Acute heart failure syndromes; lusitropic; sarco endoplasmic reticulum calcium

Indexed keywords

DIGOXIN; ISTAROXIME; PLACEBO;

ACUTE HEART FAILURE; ARTICLE; CALCIUM TRANSPORT; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; ENZYME INHIBITION; GASTROINTESTINAL SYMPTOM; HUMAN; INFUSION RELATED REACTION; KIDNEY FUNCTION; PAIN; PRACTICE GUIDELINE; TREATMENT INDICATION; VOMITING;

EID: 84878708944     PISSN: 0976500X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0976-500X.103705     Document Type: Article

References (8)

1. Huffman MD, Prabhakaran D. Heart failure: Epidemiology and prevention in India. Natl Med J India 2010;23:283-8.
2. Teerlink JR, Metra M, Zaca V, Sabbah HN, Cotter G, Gheorghiade M, et al. Agent with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond. Heart Fail Rev 2009;14:243-53.
3. Micheletti R, Palazzo F, Barassi P, Giacalone G, Ferrandi M, Schiavone A, et al. Istaroxime, a stimulator of sarcoplasmic reticulum calcium adenosine triphosphatase isoform 2a activity, as a novel therapeutic approach to heart failure. Am J Cardiol 2007;99:24A-32.
4. Alemanni M, Rocchetti M, Re D, Zaza A. Role and mechanism of subcellular Ca2+ distribution in the action of two inotropic agents with different toxicity. J Mol Cell Cardiol 2011;50:910-8.
5. Lehnart SE, Hasenfuss G. How can calcium leaks occur within heart cells? Dialogues Cardiovasc Med 2010;15:281-9.
6. Gheorghiade M, Ambrosy AP, Ferranti M, Ferrari P. Combining SERCA2a activation and Na-K ATPase inhibition: A promising new approach to managing acute heart failure syndromes with low cardiac output. Discov Med 2011;12:141-51.
7. Sabbah HN, Imai M, Cowart D, Amato A, Carminati P, Gheorghiade M. Hemodynamic properties of a new -generation positive luso-inotropic agent for the acute treatment of advanced heart failure. Am J Cardiol 2007;99:41A-6.
8. Shah SJ, Blair JE, Filippatos GS, Macarie C, Ruzyllo W, Korewicki J, et al. Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: Results from the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: A randomised controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial. Am Heart J 2009;157:1035-41.